Ozempic Starting Dose
The recommended starting dose of Ozempic (semaglutide) for adults with type 2 diabetes is 0.25 mg subcutaneously once weekly for 4 weeks, then increase to 0.5 mg once weekly. 1, 2
Dosing Algorithm
Initial Phase (Weeks 1-4):
- Start with 0.25 mg subcutaneously once weekly at any time of day
- This initial dose is NOT for glycemic control—it serves solely to minimize gastrointestinal side effects during treatment initiation 2
Maintenance Phase (Week 5 onwards):
- After 4 weeks on 0.25 mg, increase to 0.5 mg once weekly
- This is the first therapeutic dose for glycemic control 1
Dose Escalation (if needed):
- If additional glycemic control is required after at least 4 weeks on 0.5 mg, increase to 1 mg once weekly 1, 2
- For weight management indication specifically, the dose can be further titrated to 2.4 mg weekly 1
Oral Formulation Alternative
For patients who prefer oral medication, oral semaglutide is available:
- Start with 3 mg once daily taken at least 30 minutes before the first food, fluid, or other oral medications of the day
- Take with no more than 120 mL of plain water only 1
Critical Considerations
Renal Function:
- No dosage adjustments are required regardless of kidney function, including in patients with advanced CKD 1
- This is a major advantage over many other diabetes medications and makes semaglutide particularly valuable in diabetic kidney disease
Common Pitfall to Avoid: Do not skip the 0.25 mg starting dose. Many clinicians mistakenly begin at 0.5 mg thinking it will provide faster glycemic control, but this significantly increases gastrointestinal adverse events (nausea occurs in 25% of patients, vomiting and diarrhea in up to 10%) 3. The 4-week lead-in at 0.25 mg improves tolerability and long-term adherence 2.
Patient Counseling: Advise patients to eat smaller meals, drink plenty of water, increase dietary fiber, eat slowly, stop when feeling full, and avoid high-fat or spicy foods during dose initiation and escalation 3.